US BROKER MOVES: TMO upgraded at UBS; VMC downgraded at Wells Fargo

UPGRADES

• Figure Technology Solutions (FIGR) Upgraded from Underperform to Neutral at BofA Securities; PT USD 49
• Lithium Americas (LAC) Upgraded from Neutral to Overweight at JPMorgan; PT USD 6
• Lineage (LINE) Upgraded from Equalweight to Overweight at Morgan Stanley; PT USD 47
• Martin Marietta Materials (MLM) Upgraded from Equal Weight to Overweight at Wells Fargo; PT USD 609
• Sagimet Biosciences (SGMT) Upgraded from Equalweight to Overweight at Barclays; PT USD 18
• Summit Therapeutics (SMMT) Upgraded from Hold to Buy at Jefferies; PT USD 25
• Sasol (SSL) Upgraded from Neutral to Buy at BofA Securities
• Thermo Fisher Scientific (TMO) Upgraded from Neutral to Buy at UBS; PT USD 730
• UGI Corp (UGI) Upgraded from Hold to Buy at Jefferies; PT USD 43

DOWNGRADES

• Amrize (AMRZ) Downgraded from Overweight to Equal Weight at Wells Fargo; PT USD 44
• Cheche Group Inc (CCG) Downgraded from Buy to Hold at Maxim Group
• Eagle Materials (EXP) Downgraded from Overweight to Equal Weight at Wells Fargo; PT USD 196
• Patria Investments (PAX) Downgraded from Neutral to Underperform at BofA Securities; PT USD 10
• Vulcan Materials (VMC) Downgraded from Equal Weight to Underweight at Wells Fargo; PT USD 254
• Westlake (WLK) Downgraded from Outperform to Market Perform at BMO Capital; PT USD 82

INITIATIONS

• Agilent Technologies (A) Initiated at Neutral at UBS; PT USD 165
• AEON Biopharma (AEON) Initiated at Buy at Laidlaw; PT USD 1.80
• Akoustis Technologies (AKTS) Initiated at Outperform at Oppenheimer; PT USD 40
• Amneal Pharmaceuticals (AMRX) Initiated at Outperform at Leerink; PT USD 23
• ANI Pharmaceuticals (ANIP) Initiated at Outperform at Leerink; PT USD 104
• Avantor (AVTR) Initiated at Neutral at UBS; PT USD 16
• Better Home & Finance (BETR) Initiated at Buy at B. Riley; PT USD 26
• Bausch + Lomb (BLCO) Initiated at Outperform at Leerink; PT USD 24
• Bruker (BRKR) Initiated at Neutral at UBS; PT USD 65
• Caris Life Sciences (CAI) Initiated at Neutral at UBS; PT USD 28
• Chime Financial (CHYM) Initiated at Buy at Loop Capital; PT USD 45
• Cigna (CI) Initiated at In Line at Evercore ISI; PT USD 290
• Collegium Pharmaceutical (COLL) Initiated at Buy at Truist Securities; PT USD 49
• Collegium Pharmaceutical (COLL) Initiated at Outperform at Leerink; PT USD 45
• DoorDash (DASH) Initiated at Sector Outperform at Scotiabank; PT USD 275
• Dave (DAVE) Initiated at Buy at Loop Capital; PT USD 500
• Danaher (DHR) Initiated at Buy at UBS; PT USD 250
• FuelCell Energy (FCEL) Initiated at Buy at Craig; PT USD 22
• Faeth Therapeutics (FTH) Initiated at Buy at TD Cowen
• Formula One Group (FWONK) Initiated at Buy at Jefferies; PT USD 115
• Guardant Health (GH) Initiated at Buy at UBS; PT USD 225
• Grail (GRAL) Initiated at Buy at UBS; PT USD 105
• Harrow (HROW) Initiated at Outperform at Leerink; PT USD 45
• Heartflow (HTFL) Initiated at Neutral at UBS; PT USD 55
• Illumina (ILMN) Initiated at Buy at UBS; PT USD 260
• Kodiak AI (KDK) Initiated at Buy at Needham; PT USD 8
• Lindblad Expeditions (LIND) Initiated at Hold at Jefferies; PT USD 29
• Lyft (LYFT) Initiated at Sector Perform at Scotiabank; PT USD 17
• MBGL (MBGL) Initiated at In Line at Evercore ISI; PT USD 22
• Monarch Casino & Resort (MCRI) Initiated at Buy at Texas Capital Securities; PT USD 147
• Mettler-Toledo (MTD) Initiated at Neutral at UBS; PT USD 1,460
• Myriad Genetics (MYGN) Initiated at Neutral at UBS; PT USD 3.60
• Nautilus Biotechnology (NAUT) Initiated at Outperform at Leerink; PT USD 4
• Natera (NTRA) Initiated at Buy at UBS; PT USD 435
• Obsidian Therapeutics (OBX) Initiated at Outperform at William Blair
• Pacific Biosciences (PACB) Initiated at Neutral at UBS; PT USD 1.35
• Pacira BioSciences (PCRX) Initiated at Market Perform at Leerink; PT USD 28
• Phathom Pharmaceuticals (PHAT) Initiated at Market Perform at Leerink; PT USD 10
• Pulse Biosciences (PLSE) Initiated at Buy at Freedom Capital; PT USD 73
• Pursuit Attractions and Hospitality (PRSU) Initiated at Buy at Jefferies; PT USD 61
• Pasqal Holding (PSQL) Initiated at Buy at Roth; PT USD 20
• QIAGEN (QGEN) Initiated at Neutral at UBS; PT USD 47
• Repligen (RGEN) Initiated at Buy at UBS; PT USD 225
• Red Rock Resorts (RRR) Initiated at Buy at Texas Capital Securities; PT USD 72
• Revvity (RVTY) Initiated at Neutral at UBS; PT USD 140
• Sagimet Biosciences (SGMT) Initiated at Overweight at Cantor Fitzgerald
• SoFi Technologies (SOFI) Initiated at Hold at Loop Capital; PT USD 22
• Stevanato Group (STVN) Initiated at Neutral at UBS
• Tempus AI (TEM) Initiated at Neutral at UBS; PT USD 70
• Teva Pharmaceutical (TEVA) Initiated at Outperform at Leerink; PT USD 45
• TriSalus Life Sciences (TLSI) Initiated at Buy at H.C. Wainwright; PT USD 11
• Twist Bioscience (TWST) Initiated at Neutral at UBS; PT USD 144
• 10x Genomics (TXG) Initiated at Neutral at UBS; PT USD 68
• Uber (UBER) Initiated at Sector Outperform at Scotiabank; PT USD 100
• Upstart (UPST) Initiated at Hold at Loop Capital; PT USD 34
• Viatris (VTRS) Initiated at Outperform at Leerink; PT USD 20
• Waters (WAT) Initiated at Buy at UBS; PT USD 490
• West Pharmaceutical Services (WST) Initiated at Buy at UBS; PT USD 415
• XPeng (XPEV) Initiated at Neutral at UBS